Onkologie. 2017:11(6):286-288 | DOI: 10.36290/xon.2017.052
Early and late complications of cytoreductive surgery and heated intraperitoneal chemotherapy
- Onkologická klinika LF UP a FN Olomouc
Cytoreductive surgery and heated intraperitoneal chemotherapy have been gaining more popularity in the recent years. Its curativeintent is accompanied by relatively high morbidity rate. There is no unified classification system evaluating toxicity of thistreatment modality. Nevertheless there is more frequent occurrence of certain types of toxicities which differ from the toxicityof the standard digestive surgery. Early recognition of these complications results in better efficacy of the treatment but mostimportantly in better quality of life of the patients undergoing this modality of treatment. The morbidity and mortality rate is alsoinfluenced by degree of experience with this method. Therefore cytoreductive surgery and heated intraperitoneal chemotherapyshould be performed only in high-volume tertiary centres.
Keywords: cytoreductive surgery and heated intraperitoneal chemotherapy, early toxicity, long term toxicity
Published: December 1, 2017 Show citation
References
- Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006; 7: 69-76.
Go to original source... 
Go to PubMed... - Yan TD, Welch L, Black D, et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for difuse malignancy peritoneal mesothelioma. Ann Oncol 2007; 18: 827-834. Go to original source... Go to PubMed...
- Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 2007; 18: 1943-1950. Go to original source... Go to PubMed...
- Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and paliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743. Go to original source... Go to PubMed...
- Elias D, Di Pietrantonio D, Boulet T, et al."Natural history"of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2009; 35: 434-438. Go to original source... Go to PubMed...
- Elias D, Goere D, Blot F, et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 2007; 14: 1818-1824. Go to original source... Go to PubMed...
- Kusamura S, Younan R, Baratti D, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006; 106: 1144-1153. Go to original source... Go to PubMed...
- Gusani NJ, Cho SW, Colovos C, et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 2008; 15: 754-763. Go to original source... Go to PubMed...
- Baratti D, Kusamura S, Laterza B, et al. Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World journal of gastrointestinal oncology 2010; 2: 36. Go to original source... Go to PubMed...
- Makrin V, Lev-Chelouche D, Even Sapir E, et al. Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study. Journal of surgical oncology, 2005; 89(1): 18-22. Go to original source... Go to PubMed...
- Shimizu T, Maeta M, Koga S. Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Br J Surg 1991; 78: 57-59. Go to original source... Go to PubMed...
- Younan R, Kusamura S, Baratti D, et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005; 12: 910-918. Go to original source... Go to PubMed...
- Saxena A, Yan, TD, Morris DL. A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World journal of Sumery 2010; 34: 70-78. Go to original source... Go to PubMed...
- Chen MY, Chiles C, Loggie BW, et al. Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol 1997; 66: 19-23. Go to original source... Go to PubMed...
- Verwaal VJ, van Tinteren H, Ruth SV, et al. Toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2004; 85: 61-67. Go to original source... Go to PubMed...
- Votanopoulos K, Ihemelandu C, Shen P, et al. Acomparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. Journal of surgical research 2013; 179: e133-e139. Go to original source... Go to PubMed...
- Sugarbaker PH, Alderman R, Edwards G, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006; 13: 635-644. Go to original source... Go to PubMed...
- Yan TD, Edwards G, Alderman R, Marquardt CE, et al. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma-a prospective study of 70 consecutive cases. Annals of Surgical Oncology10 Oct 2006; 14(2): 515-525. Go to original source... Go to PubMed...
- Newton AD, Bartlett EK, Karakousis, GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. Journal of gastrointestinal oncology 2016; 7: 99.